CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivoXiaoli Wang, Dongsheng Li, Yan Ding et al.|Oncology Reports|2017Cited by 35